TABUTEAU HERRIOT
Insider CIK 1219927 · AXSM Chief Executive Officer, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2026-08-06 | 2026-08-07 | 4,660 | — | $0 | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2026-08-06 | 2026-08-07 | 4,660 | $4.95 | $23.1K | 11,889 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2026-08-06 | 2026-08-07 | 4,660 | $213.95 | $997.0K | 7,229 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2026-08-06 | 2026-08-07 | 4,660 | — | $0 | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2026-08-06 | 2026-08-07 | 4,660 | $213.95 | $997.0K | 7,229 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2026-08-06 | 2026-08-07 | 4,660 | $4.95 | $23.1K | 11,889 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2026-08-05 | 2026-08-07 | 45,004 | — | $0 | 4,660 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2026-08-05 | 2026-08-07 | 45,004 | $4.95 | $222.8K | 52,233 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2026-08-05 | 2026-08-07 | 45,004 | $212.01 | $9.54M | 7,229 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2026-08-05 | 2026-08-07 | 45,004 | — | $0 | 4,660 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2026-08-05 | 2026-08-07 | 45,004 | $212.01 | $9.54M | 7,229 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2026-08-05 | 2026-08-07 | 45,004 | $4.95 | $222.8K | 52,233 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2026-07-01 | 2026-07-01 | 49,666 | — | $0 | 49,664 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2026-07-01 | 2026-07-01 | 49,666 | $240.25 | $11.93M | 7,229 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2026-07-01 | 2026-07-01 | 49,666 | $4.95 | $245.8K | 56,895 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2026-06-09 | 2026-06-09 | 49,670 | — | $0 | 99,330 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2026-06-09 | 2026-06-09 | 49,670 | $241.01 | $11.97M | 7,229 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2026-06-09 | 2026-06-09 | 49,670 | $4.95 | $245.9K | 56,899 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2026-04-21 | 2026-04-23 | 24,081 | — | $0 | 24,081 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2026-02-26 | 2026-02-27 | 54,623 | — | $0 | 54,623 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2026-02-02 | 2026-02-02 | 32,410 | — | $0 | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2026-02-02 | 2026-02-02 | 32,410 | $8.02 | $259.9K | 39,639 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2026-02-02 | 2026-02-02 | 32,410 | $185.60 | $6.02M | 7,229 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2026-01-07 | 2026-01-07 | 31,261 | — | $0 | 32,410 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2026-01-07 | 2026-01-07 | 31,261 | $8.02 | $250.7K | 38,490 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2026-01-07 | 2026-01-07 | 31,261 | $170.38 | $5.33M | 7,229 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2026-01-06 | 2026-01-07 | 29,450 | — | $0 | 63,671 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2026-01-06 | 2026-01-07 | 29,450 | $8.02 | $236.2K | 36,679 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2026-01-06 | 2026-01-07 | 29,450 | $172.33 | $5.08M | 7,229 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2026-01-05 | 2026-01-07 | 78,703 | — | $0 | 93,121 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2026-01-05 | 2026-01-07 | 78,703 | $171.28 | $13.48M | 7,229 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2026-01-05 | 2026-01-07 | 78,703 | $8.02 | $631.2K | 85,932 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2025-12-04 | 2025-12-04 | 10,558 | — | $0 | 171,824 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2025-12-04 | 2025-12-04 | 10,558 | $148.18 | $1.56M | 7,229 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2025-12-04 | 2025-12-04 | 10,558 | $8.02 | $84.7K | 17,787 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2025-12-03 | 2025-12-04 | 20,163 | — | $0 | 182,382 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2025-12-03 | 2025-12-04 | 20,163 | $8.02 | $161.7K | 27,392 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2025-12-03 | 2025-12-04 | 20,163 | $146.94 | $2.96M | 7,229 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2025-12-02 | 2025-12-04 | 49,252 | — | $0 | 202,545 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2025-12-02 | 2025-12-04 | 49,252 | $8.02 | $395.0K | 56,481 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2025-12-02 | 2025-12-04 | 49,252 | $144.59 | $7.12M | 7,229 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2025-11-05 | 2025-11-05 | 21,775 | — | $0 | 251,797 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2025-11-05 | 2025-11-05 | 21,775 | $8.02 | $174.6K | 29,004 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2025-11-05 | 2025-11-05 | 21,775 | $134.49 | $2.93M | 7,229 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2025-11-04 | 2025-11-05 | 50,459 | — | $0 | 273,572 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2025-11-04 | 2025-11-05 | 50,459 | $8.02 | $404.7K | 57,688 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2025-11-04 | 2025-11-05 | 50,459 | $133.79 | $6.75M | 7,229 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2025-11-03 | 2025-11-05 | 91,705 | — | $0 | 324,031 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2025-11-03 | 2025-11-05 | 91,705 | $8.02 | $735.5K | 98,934 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2025-11-03 | 2025-11-05 | 91,705 | $132.34 | $12.14M | 7,229 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2025-10-08 | 2025-10-08 | 12,774 | — | $0 | 415,736 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2025-10-08 | 2025-10-08 | 12,774 | $118.84 | $1.52M | 7,229 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2025-10-08 | 2025-10-08 | 12,774 | $8.02 | $102.4K | 20,003 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2025-10-07 | 2025-10-08 | 13,390 | — | $0 | 428,510 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2025-10-07 | 2025-10-08 | 13,390 | $118.77 | $1.59M | 7,229 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2025-10-07 | 2025-10-08 | 13,390 | $8.02 | $107.4K | 20,619 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2025-10-06 | 2025-10-08 | 19,220 | — | $0 | 441,900 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2025-10-06 | 2025-10-08 | 19,220 | $120.17 | $2.31M | 7,229 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2025-10-06 | 2025-10-08 | 19,220 | $8.02 | $154.1K | 26,449 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2025-09-16 | 2025-09-16 | 19,719 | — | $0 | 461,120 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2025-09-16 | 2025-09-16 | 19,719 | $8.02 | $158.1K | 26,948 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2025-09-16 | 2025-09-16 | 19,719 | $114.19 | $2.25M | 7,229 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2025-09-15 | 2025-09-16 | 15,254 | — | $0 | 480,839 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2025-09-15 | 2025-09-16 | 15,254 | $8.02 | $122.3K | 22,483 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2025-09-15 | 2025-09-16 | 15,254 | $117.37 | $1.79M | 7,229 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2025-09-12 | 2025-09-16 | 27,907 | — | $0 | 496,093 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2025-09-12 | 2025-09-16 | 27,907 | $8.02 | $223.8K | 35,136 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2025-09-12 | 2025-09-16 | 27,907 | $118.96 | $3.32M | 7,229 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2025-02-24 | 2025-02-25 | 28,609 | — | $0 | 28,609 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2025-02-21 | 2025-02-25 | 28,887 | — | $0 | 28,887 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2025-02-21 | 2025-02-25 | 28,609 | — | $0 | 28,609 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2024-02-27 | 2024-02-29 | 47,886 | — | $0 | 47,886 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2024-02-27 | 2024-02-29 | 87,192 | — | $0 | 87,192 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2023-03-02 | 2023-03-06 | 110,032 | — | $0 | 110,032 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2023-03-02 | 2023-03-06 | 62,400 | — | $0 | 62,400 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2022-03-04 | 2022-03-08 | 110,861 | — | $0 | 110,861 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2022-03-04 | 2022-03-08 | 209,655 | — | $0 | 209,655 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2021-03-05 | 2021-03-09 | 51,715 | — | $0 | 51,715 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2021-03-05 | 2021-03-09 | 97,155 | — | $0 | 97,155 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2020-03-17 | 2020-03-19 | 51,691 | — | $0 | 51,691 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2020-03-17 | 2020-03-19 | 168,776 | — | $0 | 168,776 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2019-10-10 | 2019-10-15 | 68,837 | — | $0 | 68,837 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2019-03-19 | 2019-03-21 | 319,212 | — | $0 | 319,212 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2018-03-12 | 2018-04-05 | 187,628 | — | $0 | 187,628 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2017-03-15 | 2017-03-17 | 149,000 | — | $0 | 149,000 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2016-05-27 | 2016-06-01 | 524,000 | — | $0 | 524,000 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2015-11-24 | 2015-11-24 | 7,229 | — | $0 | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | C Conversion | 2015-11-24 | 2015-11-24 | 7,229 | $5.94 | $42.9K | 7,229 | SEC↗ |